Health Care: Drugs

Acura Pharmaceuticals Inc. (ACUR: NASDAQ)

$2.36 0.02 | 0.85%
05/23/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 0.00 20.47M 3.31M 3.84M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 20.47M 3.31M 3.84M
Selling, General, and Administrative Expenses 6.01M 5.90M 8.86M 11.66M
Research & Development 3.73M 4.04M 7.18M 5.67M
Operating Income before D & A (EBITDA) -9.74M 10.53M -12.72M -13.50M
Depreciation & Amortization 131.00K 131.00K 135.00K 130.00K
Interest Income 79.00K 32.00K 42.00K 147.00K
Other Income - Net -8.00K -34.00K -14.00K -3.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -9.80M 10.40M -12.83M -13.49M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -9.80M 10.40M -12.83M -13.49M
Income Taxes 0.00 147.00K 11.00K 2.48M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -9.67M 0.00 0.00 0.00
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -9.67M 0.00 0.00 0.00
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -9.67M 10.38M -12.71M -15.84M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-9.67M 0.00 0.00 0.00
Preferred Dividends
Net Income Available To Common -9.67M 0.00 0.00 0.00
Basic EPS from Continuing Ops. -0.20 0.22 -0.27 -0.35
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.20 0.22 -0.27 -0.35
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.20 0.22 -0.27 -0.35
Basic Normalized Net Income/Share -0.20 n.a. n.a. n.a.
EPS fr Continuing Ops. -0.20 0.22 -0.27 -0.35
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.20 0.22 -0.27 -0.35
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.20 0.22 -0.27 -0.35
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.20 n.a. n.a. n.a.
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ACUR

Latest ACUR Headlines from TheStreet

More Financial News for ACUR

Press Releases for ACUR

See All Press Releases

Partner Headlines for ACUR

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter